/, , /, (

ROHVWDW
i
(Q PDWLF PHWKRG IRU WKH GHWHUPLQDWLRQ RI FKROHVWHURO
LQ VHU P RU SODVPD

7KH UHD H WV D VDPSOHV VKRXO EH LVFDU H DFFRU L

,VRODWH FKROHVWHURO HWHUPL DWLR KDV D OLPLWH LD RVWLF WR WKH ORFDO UH XODWLR V L IRUFH
YDOXH +R HYHU LWV FR FH WUDWLR YDULHV L D SUH LFWDEOH D
L D ODU H XPEHU RI FOL LFDO FR LWLR V ,/, 2 *( , ,2
KROHVWHURO LV R H RI WKH IDFWRUV WKDW FR WULEXWHV WR WKH IRU URYLGHG HDJHQWV VWDEOH L UHIUL HUDWRU R
X WLO WKH
PDWLR RI DWKHURPD VL FH DWKHURVFOHURVLV FRPSOLFDWLR V DUH H SLUDWLR DWH VKR R WKH ER 'R RW H SRVH WR KL K
PDL O IRX L K SHUFKROHVWHUROHPLF L LYL XDOV WHPSHUDWXUHV IRU OR SHULR V RI WLPH
6HYHUDO HSL HPLROR LFDO VWX LHV KDYH VKR WKDW DPR
PDOHV RYHU HDUV RO WKH ULVN RI HYHORSL FRUR DU , ,/, 2 ( ( ,2 ,2 2) ( *(
KHDUW LVHDVH IRU L LYL XDOV LWK EORR FKROHVWHURO OR HU WKD OD N UHD L V RYHU 2 ' L LFDWH 5HD H W HWHULRUD
RU HTXDO WR O LV WLPHV OHVV IRU L LYL XDOV LWK RYHU WLR 'LVFDU L VXFK FDVH
OD WLPHV OHVV IRU L LYL XDOV LWK RYHU O
/(
, , /( 6HUXP RU SODVPD
7KH UHDFWLR V VWHP LV DV IROOR V D ROOHFWLRQ REWDL L WKH XVXDO D
+( E GGLWLYHV KH XVL SODVPD LW LV UHFRPPH H WR XVH
FKROHVWHURO HVWHUV FKROHVWHURO IDWW DFL V R O KHSDUL DV D WLFRD XOD W WR REWDL LW
F .QRZQ LQWHUIHULQJ V EVWDQFHV
+2'
:LWK WKH H FHSWLR RI KHSDUL FRPPR D WLFRD XOD WV
FKROHVWHURO 2 FKROHVWH R H +2
L WHUIHUH LWK WKH WHVW
32' 'R RW XVH VHUD LWK YLVLEOH RU L WH VH KHPRO VLV VL FH WKH
+2 3 DFFHSWRU TXL R HLPL H OHD WR IDOVHO L FUHDVH UHVXOWV
1R L WHUIHUH FHV DUH REVHUYH IURP ELOLUXEL XS WR P O DVFRU
2 , ( ( *( ELF DFL XS WR P O XULF DFL XS WR P O PLO KHPRO VLV
WDQGDUG O FKROHVWHURO VROXWLR 6HH <RX ' 6 L 5eferences for e ect of drugs on the
HDJHQW VROXWLR FR WDL L FKROHVWHURO HVWHUDVH SUHVH W PHWKR
+( FKROHVWHURO R L DVH +2' SHUR L DVH 32' G WDELOLW DQG VWRUDJH LQVWU FWLRQV LWKRXW SUHVHUYD
4-amino-phenazone (4-AP) and Good bu er, which contains WLYHV VHUXP FKROHVWHURO LV VWDEOH IRU DW OHDVW HHN L D
SKH RO D VR LXP FKRODWH L WKH IROOR L FR FH WUDWLR V UHIUL HUDWRU D PR WKV L D IUHH HU
+( ≥ 8O
+2' ≥ 8O ( , ( ( , / R SURYL H
32' ≥ 8O 6SHFWURSKRWRPHWHU RU SKRWRFRORULPHWHU
3 PPRO O 0LFURSLSHWWHV D SLSHWWHV IRU PHDVXUL WKH VWDWH YROXPHV
Good PPRO O 7XEHV RU VSHFWURSKRWRPHWULF FXYHWWHV
3KH RO PPRO O :DWHU EDWK DW R
6R LXP FKRODWH PPRO O 6WRS DWFK

2 2 , ( ( *( 2 , ,2
:LH HU ODE V DOLEUDGRU O V - Wavelength: 505 nm in spectrophotometer or 490-530 nm
in photocolorimeter with green lter.
, ,2 )2 ( 5HDFWLR WHPSHUDWXUH R

URYLGHG HDJHQWV UHD WR XVH 5HDFWLR WLPH PL XWHV

6DPSOH YROXPH XO
: , * 5HD H W YROXPH PO
5HD H WV DUH IRU L YLWUR LD RVWLF XVH )L DO UHDFWLR YROXPH PO
8VH WKH UHD H WV DFFRU L WR WKH RUNL SURFH XUHV IRU 6DPSOH D 5HD H W YROXPHV PD EH YDULH SURSRUWLR DOO
FOL LFDO ODERUDWRULHV H XO 6DPSOH PO 5HD H W

N
 ( )2 (
2 ( ( D HSURG FLELOLW SURFHVVL UHSOLFDWHV RI WKH VDPH VDP
, WKUHH WXEHV RU VSHFWURSKRWRPHWHU FXYHWWHV ODEHOH ples in 10 di erent days, the following results were obtained:
OD N 6 6WD DU D 8 8 N R SODFH /HYHO 6'
6 8 O ± 0.043 g/l 3.49 %
O ± 0.115 g/l 3.48 %
WDQGDUG XO
E HFRYHU adding known amounts of cholesterol to di er
DPSOH XO
ent sera, for cholesterol levels between 1.90 and 4.79 g/l, a
HDJHQW PO PO PO recovery between 98 and 101% was obtained.
, FXEDWH PL XWHV L DWHU EDWK DW R RU PL XWHV F HWHFWLRQ OLPLW LW HSH V R WKH SKRWRPHWHU XVH )RU
DW URRP WHPSHUDWXUH R
5HD L VSHFWURSKRWRP D 2 ' UHD L WKH PL LPXP HWHFWDEOH FKD H RI
eter at 505 nm or in photocolorimeter with green lter FR FH WUDWLR LOO EH RI DSSUR LPDWHO O
(490-530 nm), setting the instrument to zero with the G /LQHDULW WKH UHDFWLR LV OL HDU XS WR O )RU KL KHU YDO
OD N XHV LOXWH LWK OD N D UHSHDW WKH UHD L PXOWLSO L
the nal result by 2.

( ( )2 2 / (
,/, 2) ), / ( ,2
)RU SUR UDPPL L VWUXFWLR V FKHFN WKH XVHU V PD XDO RI
)L DO UHDFWLR FRORU LV VWDEOH IRU PL XWHV WKXV DEVRUED FH
WKH DXWRD DO HU L XVH
VKRXO EH UHD LWKL WKDW SHULR
)RU FDOLEUDWLR XVH :LH HU ODE V DOLEUDGRU O V IROOR L
WKH DXWRD DO HU UHTXLUHPH WV
/ / ,2
O :,( ( / 2 , (
FKROHVWHURO O ' I KHUH I
6 PO 6WD DU DW 1
PO 6WD DU DW 1
- 6 x 60 ml (Cat. Nº 1009308).
, 2 ( ,2 - 6 x 60 ml (Cat. Nº 1009610).
FKROHVWHURO O FKROHVWHURO P O PO DW 1
cholesterol (mmol/l) = cholesterol (g/l) x 2.59 - 12 x 50 ml (Cat. Nº 1009253).
cholesterol (g/l) = cholesterol (mmol/dl) x 0.39 - 4 x 40 ml (Cat. Nº 1009802).

/, 2 2/ ( 2 8VL ROHVWDW HQ LPiWLFR OtT LGD DOR LWK /

(DFK WLPH WKH WHVW LV SHUIRUPH D DO H W R OHYHOV RI D TXDO ROHVWHURO HDFWLYR UHFLSLWDQWH / ROHVWHURO ) D
LW FR WURO PDWHULDO WDQGDWURO ( QLYHOHV LWK N R / / ROHVWHURO HDFWLYR UHFLSLWDQWH VHSDUDWHO SURYL H
FKROHVWHURO FR FH WUDWLR E :LH HU ODE LW LV SRVVLEOH WR HWHUPL H WKH KL K H VLW
OLSRSURWHL FKROHVWHURO +'/ KROHVWHURO D OR H VLW
()( ( ( / ( OLSRSURWHL FKROHVWHURO /'/ KROHVWHURO
7KH 1DWLR DO KROHVWHURO ( XFDWLR 3UR UDP 1 (3 ( SHUW
3D HO SURYL H WKH IROOR L UHIHUH FH YDOXHV ()( ( (
- Abell, L.L. et al. - J. Biol. Chem. 195:357 (1952).
'HVLUDEOH O - Allain, C.C. et al.. - Clin. Chem. 20:470 (1974).
Borderline high: 2.00 - 2.39 g/l PHULFD +HDOWK )RX DWLR 3RVLWLR VWDWHPH W R LHW
+L K ≥ O and coronary heart disease - pág. 255 (1972).
,W LV UHFRPPH H WKDW HDFK ODERUDWRU HVWDEOLVKHV LWV R - I.F.C.C. - Clin. Chim. Acta 87/3:459 F (1978).
L WHUYDOV D UHIHUH FH YDOXHV - Trinder, P. - Ann. Clin. Biochem. 6/24 (1969).
- Coniglio R.I. - Acta Bioq. Clin. Latinoam. XXIII/2:201 (1989).
2 ( ( /, , ,2 ( SHUW 3D HO RI 1DWLR DO KROHVWHURO ( XFDWLR 3UR UDP
6HH . R L WHUIHUL VXEVWD FHV X HU 6 03/( JAMA 285/19:2486 (2001).
5H XFL D H WV HFUHDVH WKH FRORU UHVSR VH KLOH R L - Young, D.S. - "E ects of Drugs on Clinical Laboratory Tests",
D WV FRORU WKH 5HD H W L FUHDVL WKH OD NV 3UHVV WK H
'HWHU H WV KHDY PHWDOV D F D L HV DUH H PH L KLEL
WRUV
Do not use the Standard in autoanalyzers due to the di erent
VXUIDFH WH VLR L UH DU V WR VHUXP FDXVH E WKH VROYH W
XVH L LWV SUHSDUDWLR
,W LV UHFRPPH H WR SHUIRUP R H HHNO FDOLEUDWLR RU HDFK
WLPH YDOXHV RXWVL H WKH DFFHSWDEOH R WUROV 6WD DWURO 6 (
LYHOHV RUPDO UD H DUH REWDL H